Active Ingredient(s): Tiludronate
FDA Approved: * March 7, 1997
Pharm Company: * SANOFI AVENTIS US
Category: Paget's Disease

Tiludronic acid (INN; also known as tiludronate) is a bisphosphonate used for treatment of Paget's disease of bone (osteitis deformans) in human medicine. It has the tradename Skelid. In veterinary medicine, tiludronic acid is used to treat navicular disease and bone spavin in horses. Its tradenames are Tildren and Equidronate. It is approved for treatment of navicular disease and distal tarsal osteoarthritis in Europe,[1] and was approved for treatment of navicular disease i... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Skelid 200 mg (As Tiludronate Disodium 240 mg) Oral Tablet
NDC: 0024-1800
Sanofi-aventis U.S. LLC